KOREA PHARMA Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	29,450	27,530	21,909	41,424	8,390	56,540
Short-Term Investments	-	-	-	-	2,000	6,000
Trading Asset Securities	-	-	15,786	6,889	52,690	-
Cash & Short-Term Investments	29,450	27,530	37,695	48,313	63,080	62,540
Cash Growth	-19.47%	-26.97%	-21.98%	-23.41%	0.86%	231.52%
Accounts Receivable	14,976	13,754	14,947	14,049	15,331	16,756
Other Receivables	1,335	689.03	595.3	574.37	587.96	441.83
Receivables	16,311	14,443	15,542	14,624	16,419	17,598
Inventory	21,826	22,161	18,906	18,546	17,292	16,910
Prepaid Expenses	47.28	48.22	53.73	82.9	128.49	78.92
Other Current Assets	553.59	187.53	1,436	3,819	1,163	108.56
Total Current Assets	68,188	64,369	73,634	85,385	98,083	97,236
Property, Plant & Equipment	22,562	22,914	24,010	23,534	22,130	20,149
Long-Term Investments	10,120	9,861	5,836	4,003	3,383	4,375
Other Intangible Assets	3,163	3,341	3,962	3,497	2,865	2,973
Long-Term Deferred Tax Assets	830.97	1,035	-	-	563.51	669.94
Long-Term Deferred Charges	541.63	573.17	958.9	907.84	-	-
Other Long-Term Assets	24,566	24,547	3,987	3,977	3,923	3,998
Total Assets	129,971	126,640	112,387	121,303	130,947	129,401
Accounts Payable	8,413	6,708	7,400	7,284	7,098	6,721
Accrued Expenses	2,265	2,223	909.52	699	863.27	857.23
Short-Term Debt	26,424	25,588	4,000	18,080	50,774	7,000
Current Portion of Long-Term Debt	12,000	12,000	-	-	2,560	2,960
Current Portion of Leases	686.25	635.95	255.64	661.11	567.64	529.03
Current Income Taxes Payable	120.58	129	721.31	171.1	9.13	180.54
Other Current Liabilities	9,846	9,285	6,034	6,405	7,663	7,250
Total Current Liabilities	59,755	56,568	19,321	33,300	69,535	25,498
Long-Term Debt	-	-	18,542	15,926	-	43,121
Long-Term Leases	661.02	713.7	104.14	197.12	727.27	116.67
Pension & Post-Retirement Benefits	496.18	450.06	2,397	1,977	869.13	3,198
Long-Term Deferred Tax Liabilities	-	-	581.32	1,322	-	-
Other Long-Term Liabilities	125.16	122.83	-0	0	-0	-0
Total Liabilities	61,037	57,854	40,946	52,722	71,132	71,934
Common Stock	5,453	5,453	5,453	5,453	5,453	5,453
Additional Paid-In Capital	29,569	38,869	39,169	39,169	31,175	23,407
Retained Earnings	30,127	20,690	22,411	19,694	21,750	26,019
Comprehensive Income & Other	3,785	3,774	4,408	4,265	1,436	2,588
Shareholders' Equity	68,934	68,786	71,441	68,582	59,815	57,467
Total Liabilities & Equity	129,971	126,640	112,387	121,303	130,947	129,401
Total Debt	39,772	38,937	22,902	34,864	54,629	53,727
Net Cash (Debt)	-10,321	-11,408	14,793	13,449	8,451	8,813
Net Cash Growth	-	-	10.00%	59.13%	-4.11%	79.40%
Net Cash Per Share	-948.90	-953.91	1357.71	1284.46	777.88	801.30
Filing Date Shares Outstanding	10.83	10.91	10.91	10.91	10.91	10.91
Total Common Shares Outstanding	10.83	10.91	10.91	10.91	10.91	10.91
Working Capital	8,433	7,802	54,313	52,085	28,548	71,738
Book Value Per Share	6363.34	6306.79	6550.23	6288.02	5484.28	5268.98
Tangible Book Value	65,771	65,446	67,479	65,084	56,950	54,494
Tangible Book Value Per Share	6071.35	6000.49	6186.97	5967.35	5221.60	4996.41
Land	11,097	11,097	11,097	11,097	8,067	6,933
Buildings	15,819	15,819	15,819	15,571	15,033	15,094
Machinery	14,566	14,542	13,222	12,560	11,697	11,365
Construction In Progress	245.41	245.41	2,354	952.42	2,039	998.96